The new fluoride? FDA greenlights rapamycin oral health trial
Trial to evaluate rapamycin in periodontal disease gets FDA go-ahead – Matt Kaeberlein’s Optispan to monitor aging biomarkers.
Most Popular
The new fluoride? FDA greenlights rapamycin oral health trial
Trial to evaluate rapamycin in periodontal disease gets FDA go-ahead – Matt Kaeberlein’s Optispan to monitor aging biomarkers.
Stanford organ aging study spawns new longevity startup
Biotech company Teal Omics founded after researchers develop algorithm that measures how fast individual organs are aging.
Hevolution pumps another $40 million into aging research projects
Aging research organizations including the Buck and AFAR benefit as Global Healthspan Summit funding commitments reach $100m.
Could XPRIZE Healthspan deliver the ‘holy grail’ for longevity science?
XPRIZE exec director Dr Jamie Justice on how the $101m competition can deliver a lasting legacy to the longevity field.
Supplements
NIH-funded longevity study shows astaxanthin extends lifespan
Research from Interventions Testing Program on astaxanthin represents advance in longevity supplements field.
Editor's pick
Interface Bio emerges with $3m to harness the microbiome against inflammation
AI-powered platform identifies bacterial natural products with the potential to modulate the immune system and reduce inflammation.
Biolexis lands $10m to advance metabolic drug program with longevity potential
AI-powered drug discovery company is developing metabolic drug candidates targeting obesity, diabetes and human longevity.
Hevolution pumps another $40 million into aging research projects
Aging research organizations including the Buck and AFAR benefit as Global Healthspan Summit funding commitments reach $100m.
XPRIZE Healthspan offers $101m prize for successful longevity therapeutic
Winners will need to demonstrate their longevity therapy can restore muscle, cognition, and immune function by up to 20 years.
Watch now
‘There will be a point where we solve aging – this decade is that moment in time’
XPRIZE founder Peter Diamandis on the biggest prize the world has ever seen – and why a successful outcome will mean we'll all be winners.
Physicians want AI tech to help dementia patients live longer
Two-thirds of UK GPs want to prescribe tech for their dementia patients to help them remain independent and live longer.
Connected technologies are changing the future of aging at home
Huong Le Dieu, Lead Product Manager of BLabs at Baracoda Daily Healthtech, on why it's time to take aging in place to the next level.
AI innovations to transform living with dementia awarded £1.9 million
Longitude Prize on Dementia champions personalized tech that to helps people living with dementia enjoy independent and fulfilled lives.
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech
Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.
